Cargando…

Some considerations on target estimands for health technology assessment

Detalles Bibliográficos
Autor principal:	Remiro‐Azócar, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828791/ https://www.ncbi.nlm.nih.gov/pubmed/36385477 http://dx.doi.org/10.1002/sim.9566

Ejemplares similares

Understanding estimands
por: Gogtay, Nithya Jaideep, et al.
Publicado: (2021)

Estimands for factorial trials
por: Kahan, Brennan C., et al.
Publicado: (2022)

Two-stage matching-adjusted indirect comparison
por: Remiro-Azócar, Antonio
Publicado: (2022)

Correction: Two-stage matching-adjusted indirect comparison
por: Remiro‑Azócar, Antonio
Publicado: (2022)

Estimands and Complex Innovative Designs
por: Collignon, Olivier, et al.
Publicado: (2022)

What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?
por: Lawrance, Rachael, et al.
Publicado: (2020)

Estimands in epigenome-wide association studies
por: Kruppa, Jochen, et al.
Publicado: (2021)

Estimands—What they are and why they are important for pharmacometricians
por: Akacha, Mouna, et al.
Publicado: (2021)

Eliminating Ambiguous Treatment Effects Using Estimands
por: Kahan, Brennan C, et al.
Publicado: (2023)

Parametric G‐computation for compatible indirect treatment comparisons with limited individual patient data
por: Remiro‐Azócar, Antonio, et al.
Publicado: (2022)

Rethinking intercurrent events in defining estimands for tuberculosis trials
por: Pham, Tra My, et al.
Publicado: (2022)

Individualism and social solidarity in vaccination policy: some further considerations
por: Sim, Fiona M.
Publicado: (2017)

Estimands: bringing clarity and focus to research questions in clinical trials
por: Clark, Timothy Peter, et al.
Publicado: (2022)

Principles and recommendations for incorporating estimands into clinical study protocol templates
por: Lynggaard, Helle, et al.
Publicado: (2022)

Translating questions to estimands in randomized clinical trials with intercurrent events
por: Stensrud, Mats J., et al.
Publicado: (2022)

Estimands to quantify prolonged hospital stay associated with nosocomial infections
por: Wolkewitz, Martin, et al.
Publicado: (2019)

Estimands in published protocols of randomised trials: urgent improvement needed
por: Kahan, Brennan C., et al.
Publicado: (2021)

Why estimands are needed to define treatment effects in clinical trials
por: Keene, Oliver N., et al.
Publicado: (2023)

Commentary: Estimands in cluster trials: thinking carefully about the target of inferenceand the consequences for analysis choice
por: Hemming, Karla, et al.
Publicado: (2022)

Some considerations on the current debate about typing resolution in solid organ transplantation
por: Vogiatzi, Paraskevi
Publicado: (2016)

Marking 2-Years of New Thinking in Clinical Trials: The Estimand Journey
por: Fletcher, C., et al.
Publicado: (2022)

Re-randomisation trials in multi-episode settings: Estimands and independence estimators
por: Kahan, Brennan C, et al.
Publicado: (2022)

Estimands in cluster-randomized trials: choosing analyses that answer the right question
por: Kahan, Brennan C, et al.
Publicado: (2022)

Artificial intelligence to improve rehabilitation care for children with developmental conditions: Some ethical considerations
por: van der Veen, Sabina, et al.
Publicado: (2022)

On estimands and the analysis of adverse events in the presence of varying follow‐up times within the benefit assessment of therapies
por: Unkel, Steffen, et al.
Publicado: (2018)

Making sense of technology adoption in healthcare: meso-level considerations
por: May, Carl R
Publicado: (2015)

Payer Perspectives on Health Technology Assessment
por: Watkins, John B.
Publicado: (2012)

COVID-19, anorexia nervosa and obese patients with an eating disorder - some considerations for practitioners and researchers
por: Simeunovic Ostojic, Mladena, et al.
Publicado: (2021)

Beyond “Intent‐to‐treat” and “Per protocol”: Improving assessment of treatment effects in clinical trials through the specification of an estimand
por: Pétavy, Frank, et al.
Publicado: (2020)

Target estimands for efficient decision making: Response to comments on “Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study”
por: Phillippo, David M., et al.
Publicado: (2021)

Blockchains, Formulary Evaluations and Health Technology Assessment
por: Langley, Paul C, et al.
Publicado: (2018)

COVID-19 Challenge, Information Technologies, and Smart Cities: Considerations for Well-Being
por: Abusaada, Hisham, et al.
Publicado: (2020)

Evaluating how clear the questions being investigated in randomised trials are: systematic review of estimands
por: Cro, Suzie, et al.
Publicado: (2022)

Hypothetical Estimands in Clinical Trials: A Unification of Causal Inference and Missing Data Methods
por: Olarte Parra, Camila, et al.
Publicado: (2022)

Analytical approaches and estimands to take account of missing patient-reported data in longitudinal studies
por: Bell, Melanie L, et al.
Publicado: (2019)

Impact of a Global Pandemic on Health Technology Assessment
por: Lorgelly, Paula K., et al.
Publicado: (2020)

Glutamate transporter: an unexpected target for some antibiotics
por: Mao, Jianren
Publicado: (2005)

Genomic medicine: considerations for health professionals and the public
por: Avard, Denise, et al.
Publicado: (2009)

Functional Loss and Mortality in Randomized Clinical Trials for Amyotrophic Lateral Sclerosis: To Combine, or Not to Combine—That is the Estimand
por: van Eijk, Ruben P.A., et al.
Publicado: (2022)

A narrative review of estimands in drug development and regulatory evaluation: old wine in new barrels?
por: Mitroiu, M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c14bgjiqc55btbhlsfvveh0bbe